We are analyzing https://link.springer.com/chapter/10.1007/978-1-4899-0949-7_5.

Title:
Vitamin D and Prostate Cancer | SpringerLink
Description:
An analysis of the rising incidence and mortality rate of prostate cancer reveals the extraordinary importance of this disease in the world. Adenocarcinoma of the prostate is the most common cancer diagnosed in American males, reaching an estimated incidence of 32%,...
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

cancer, google, scholar, cas, pubmed, prostate, article, vitamin, dihydroxyvitamin, human, feldman, receptors, chapter, cell, steroid, skowronski, peehl, carcinoma, prostatic, receptor, colon, res, garland, endocrinology, colston, differentiation, privacy, cookies, content, information, publish, book, mortality, download, endocrine, cells, role, biochem, springer, analysis, search, medicine, men, preview, clin, study, stamey, pike, expression, usa,

Topics {✒️}

month download article/chapter cas google scholar human prostatic cells human prostatic carcinoma age-adjusted mortality rate privacy choices/manage cookies human keratinocytes varies major adverse factors device instant download mosby year book human colon adenocarcinoma common cancer diagnosed primary prostatic carcinoma bone cell phehnotype mol cell endocrinol european economic area extremely common finding utah mormon genealogy 25-dihydroxy-16ene-23yne-26 prostate cancer reveals subclinical prostate cancer prostate cancer represents makes prostate cancer residual prostate cancer journal finder publish download preview pdf colon cancer incidence prostate specific antigen male cancer deaths google scholar prostate cancer mortality bone matrix competency intestinal cell differentiation ann rev nutr steroid receptor superfamily endocrine dependent pathology male sex organs accepting optional cookies risk factor year prospective study calcium binding proteins stanford university school chick intestinal receptors cell proliferation steroid receptor profile chapter cite plasma steroid levels conditions privacy policy main content log 25-dihydroxyvitamin d3 receptor

Questions {❓}

Garland, Do vitamin D and sunlight reduce the likelihood of colon cancer?
Gorham, Can colon cancer incidence and death rates be reduced with calcium and vitamin D?
Hulka, Is Vitamin D deficiency a risk factor for prostate cancer?

Schema {🗺️}

ScholarlyArticle:
      headline:Vitamin D and Prostate Cancer
      pageEnd:63
      pageStart:53
      image:https://media.springernature.com/w153/springer-static/cover/book/978-1-4899-0949-7.jpg
      genre:
         Biomedical and Life Sciences
         Biomedical and Life Sciences (R0)
      isPartOf:
         name:Diet and Cancer
         isbn:
            978-1-4899-0949-7
            978-1-4899-0951-0
         type:Book
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:David Feldman
            affiliation:
                  name:Stanford University School of Medicine
                  address:
                     name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Roman J. Skowronski
            affiliation:
                  name:Stanford University School of Medicine
                  address:
                     name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Donna M. Peehl
            affiliation:
                  name:Stanford University School of Medicine
                  address:
                     name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      keywords:Prostate Cancer, Prostate Specific Antigen, Benign Prostatic Hyperplasia, Prostate Cancer Cell, LNCaP Cell
      description:An analysis of the rising incidence and mortality rate of prostate cancer reveals the extraordinary importance of this disease in the world. Adenocarcinoma of the prostate is the most common cancer diagnosed in American males, reaching an estimated incidence of 32%, with 200,000 cases of newly diagnosed cancer cases expected in 1994.1 In addition, clinically inapparent prostate cancer is an extremely common finding. Over the age of 80, subclinical prostate cancer is found in approximately 60% of all men.2 Overall, it is estimated that there are 11 million men in the U.S. with lesions within their prostates that are histologically identifiable as cancer.3 Mortality from prostate cancer represents a considerable problem. It is expected that prostate cancer will account for 13% (38,000 cases) of male cancer deaths in 1994.1 This makes prostate cancer the second leading cause of cancer-related death in U.S. men after lung cancer. Mortality rates from prostate cancer appear to be on the rise. From 1970 to 1990 the age-adjusted mortality rate from prostate cancer increased approximately 7 % among U.S. caucasians. Since prostate cancer rates increase with age, as the longevity of the population increases, it is projected that prostate cancer will become the leading cause of cancer and cancer death in men. These observations demonstrate that prostate cancer is one of the major adverse factors in the health of the male population in the United States and for that matter, in the rest of the world as well.
      datePublished:1995
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
      context:https://schema.org
Book:
      name:Diet and Cancer
      isbn:
         978-1-4899-0949-7
         978-1-4899-0951-0
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Stanford University School of Medicine
      address:
         name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
         type:PostalAddress
      name:Stanford University School of Medicine
      address:
         name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
         type:PostalAddress
      name:Stanford University School of Medicine
      address:
         name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:David Feldman
      affiliation:
            name:Stanford University School of Medicine
            address:
               name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
               type:PostalAddress
            type:Organization
      name:Roman J. Skowronski
      affiliation:
            name:Stanford University School of Medicine
            address:
               name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
               type:PostalAddress
            type:Organization
      name:Donna M. Peehl
      affiliation:
            name:Stanford University School of Medicine
            address:
               name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
      name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
      name:Departments of Medicine and Urology (D.M.P.), Stanford University School of Medicine, Stanford, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(165)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js

4.13s.

LINK . SPRINGER . COM {}